Meeting details menu

Meeting Authors
Meeting Abstracts
Keynote lectures
Oral communications
Poster presentations
Special symposia
Other

Acta Physiologica Congress

Back

Acta Physiologica 2009; Volume 196, Supplement 671
Scandinavian Physiological Society’s Annual Meeting
8/14/2009-8/16/2009
Uppsala, Sweden


VASODILATION BY PERIVASCULAR FAT: MODULATION BY STEROIDS
Abstract number: P5

ANDERSEN1 I, LI1 R, NILSSON1 H

1Department of Physiology, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, P.O.Box 432, S-405 30 Gothenburg, Sweden. [email protected]

Adipose tissue has been shown to release a transferable factor that relaxes vascular smooth muscle; the precise nature of this factor is as yet unknown (Gollasch & Dubrowska 2004). It has been suggested that the vasodilator function of perivascular fat is reduced in obesity (Greenstein et al. 2009) and that activity of 11ß-HSD-1 reductase is elevated in obese patients (Rask et al. 2002). We thus wanted to determine whether steroids modulate the vasodilator mechanism of adipose tissue.

Mesenteric small arteries from adult Sprague-Dawley rats were isolated and mounted in a Mulvany-Halpern myograph. All vessels were initially cleaned of perivascular fat and their noradrenaline sensitivity determined. Subsequently, perivascular fat was wrapped around every other blood vessel and noradrenaline sensitivity determined again. Finally corticosterone (10 mM) was added 10 min before a third determination of noradrenaline sensitivity.

Application of fat caused a significant reduction in noradrenaline sensitivity (D(log EC50) -0.581 ± 0.109, n=7) and a reduction in maximal response (-12.7 ± 3.8 %). Addition of corticosterone partially antagonised the effect of fat: sensitivity increased by D(log EC50) 0.345 ± 0.121 compared to fat without corticosterone. In vessels without perivascular fat corticosterone did not induce any significant effects.

These preliminary data suggest that steroids may acutely modulate the vasodilator mechanism of perivascular fat.

Gollasch M, Dubrovska G. Trends Pharmacol Sci 2004;25:647–53.

Greenstein AS, Khavandi K, Withers SB, Sonoyama K, Clancy O, Jeziorska M, et al. Circulation 2009;119:1661–70.

Rask E, Walker BR, Soderberg S, Livingstone DE, Eliasson M, Johnson O, et al. J Clin Endocrinol Metab 2002;87:3330–6.

To cite this abstract, please use the following information:
Acta Physiologica 2009; Volume 196, Supplement 671 :P5

Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.

By continuing to browse this site you agree to us using cookies as described in our standard cookie policy .

CLOSE